Development Level

Tbio 3 | 10,625
Tchem 3 | 1,890

IMPC Term

increased circulating calcium ... 2 | 32
decreased circulating LDL chol... 1 | 37
increased erythrocyte cell num... 1 | 26
increased total body fat amoun... 1 | 57
preweaning lethality, complete... 1 | 633
preweaning lethality, incomple... 1 | 260

Disease

glioblastoma 5 | 5,572
lung cancer 5 | 4,466
lung carcinoma 5 | 2,844
ovarian cancer 5 | 8,484
psoriasis 5 | 6,685
Arthritis 4 | 248
Asthma 4 | 349
Cancer 4 | 2,346
Lung disease 4 | 132
acute myeloid leukemia 4 | 780
atypical teratoid / rhabdoid tumor 4 | 4,369
cystic fibrosis 4 | 1,665
interstitial cystitis 4 | 2,299
malignant mesothelioma 4 | 3,162
posterior fossa group A ependymoma 4 | 1,511
subependymal giant cell astrocytoma 4 | 2,287
tuberculosis 4 | 1,557
Atherosclerosis 3 | 275
Dermatitis 3 | 107
Inflammatory bowel disease 3 | 142
Pick disease 3 | 1,893
adult high grade glioma 3 | 2,148
astrocytoma 3 | 1,493
colon cancer 3 | 1,475
non-small cell lung cancer 3 | 2,798
oligodendroglioma 3 | 2,849
pilocytic astrocytoma 3 | 3,086
primitive neuroectodermal tumor 3 | 3,031
Allergic hypersensitivity disease 2 | 123
Allergic rhinitis 2 | 91
Barrett's esophagus 2 | 183
Common cold 2 | 63
Coronary artery disease 2 | 240
Endometriosis 2 | 535
Eosinophilia 2 | 65
Glomerulonephritis 2 | 36
Hepatitis, Autoimmune 2 | 17
Human immunodeficiency virus infectious disease 2 | 92
Hypersensitivity reaction type II disease 2 | 235
Influenza 2 | 142
Keratitis 2 | 42
Kidney disease 2 | 396
Liver carcinoma 2 | 217
Mammary Neoplasms 2 | 410
Meningitis 2 | 46
Multiple Sclerosis 2 | 498
Pancreatic Neoplasm 2 | 79
Pulmonary Fibrosis 2 | 66
Reperfusion Injury 2 | 84
Rheumatoid Arthritis 2 | 1,160
Severe acute respiratory syndrome 2 | 26
active Crohn's disease 2 | 918
cutaneous lupus erythematosus 2 | 1,056
diabetes mellitus 2 | 1,663
ependymoma 2 | 2,514
esophageal adenocarcinoma 2 | 737
gastric carcinoma 2 | 832
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
invasive ductal carcinoma 2 | 2,950
lung adenocarcinoma 2 | 2,713
medulloblastoma, large-cell 2 | 6,234
mucosa-associated lymphoid tissue lymphoma 2 | 480
nasopharyngeal carcinoma 2 | 1,056
pancreatic cancer 2 | 2,300
periodontitis 2 | 269
sarcoidosis 2 | 358
ulcerative colitis 2 | 2,087
Adenocarcinoma 1 | 115
Ankylosing spondylitis 1 | 138
Barrett Esophagus 1 | 16
Bipolar Disorder 1 | 266
Brain disease 1 | 83
Bronchial Hyperreactivity 1 | 13
Bronchitis 1 | 44
Chronic Obstructive Airway Disease 1 | 47
Colorectal Neoplasms 1 | 217
Diarrhea 1 | 155
Drug-Induced Liver Injury 1 | 118
Encephalitis 1 | 54
Endometrial Neoplasms 1 | 50
Fatty Liver 1 | 48
Gastritis 1 | 44
Gastrointestinal system disease 1 | 50
Hodgkin Disease 1 | 16
Juvenile rheumatoid arthritis 1 | 104
Lambert-Eaton myasthenic syndrome 1 | 14
Leukopenia 1 | 42
Liver disease 1 | 219
Mastitis 1 | 48
Neoplastic Cell Transformation 1 | 81
Osteoarthritis 1 | 96
Otitis media 1 | 32
Pain 1 | 70
Pancreatitis 1 | 97
Pulmonary hypertension 1 | 52
Respiratory Hypersensitivity 1 | 18
Squamous cell carcinoma 1 | 94
Streptococcal pneumonia 1 | 6
Thyroid Neoplasm 1 | 33
ovarian neoplasm 1 | 97

Tissue

Blood and immune system 6 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Nervous System 5 | 18,561
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444

Target Family

Non-IDG 6 | 11,971

Grant Application

5R01HL060207-04 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
NF-kappa-B inhibitor alpha NFKBIA Tchem Non-IDG -3.34160 1960.9 1181
C-C motif chemokine 5 CCL5 Tchem Non-IDG -3.34675 2314.5 487
Interleukin-8 CXCL8 Tchem Non-IDG -3.96313 9346.7 993
Synaptotagmin-1 SYT1 Tbio Non-IDG -2.63179 445.8 573
Growth-regulated alpha protein CXCL1 Tbio Non-IDG -3.07681 1174.2 351
Rho guanine nucleotide exchange factor 7 ARHGEF7 Tbio Non-IDG -2.12237 139.1 160